Dienstag, 27.09.2016 Börsentäglich über 12.000 News von 546 internationalen Medien



24 h / 7 T
7 Tage



24 h / 7 T
7 Tage








Passende Knock-Outs zu Ihrer Suchanfrage (Anzeige)
Ad hoc-Mitteilungen
23.09.2016 | 16:12
(5 Leser)
Schrift ändern:
(0 Bewertungen)

PR Newswire·Mehr Nachrichten von PR Newswire

DUBLIN, September 23, 2016 /PRNewswire/ --

Dublin - Research and Markets has announced the addition of the "US Market Report for Cardiac Output Monitoring 2017 - MedCore" report to their offering.

The market for cardiac output monitoring includes pulmonary artery catheters (PAC), minimally invasive, and non-invasive monitoring devices as well as the sensors associated with each of these modalities. In recent years, less invasive technologies have displaced the PAC, as physicians move towards reliable techniques that reduce the impact on patients. However, while less invasive solutions continue to gain traction, it has been suggested that they are not as accurate when compared with traditional PAC thermodilution methods. As such, PAC procedures are still considered the gold standard for calculating cardiac output as well as performing other essential measurements related to drug administration, particularly in high risk surgical theaters.

The total cardiac output market will continue to see strong growth over the forecast period due to increased awareness of the efficacy of CO monitoring. This measurement has become an integral part of critical care practice and may help in facilitating improved patient outcomes. Operating rooms (ORs) have traditionally been the primary users of cardiac output monitoring and pulmonary artery catheters (PACs). Newer therapies are geared toward quickly identifying patient conditions on the front line, namely within intensive care units (ICUs) and emergency rooms (ERs), where CO may be utilized as an early warning indicator for circulatory disturbances.

Cardiac output (CO) refers to the volume of blood being pumped by the heart. Monitoring of patient cardiac output is rapidly becoming a standard of care and a vital part of early diagnosis and treatment. It is also important in the management of heart attacks and for monitoring of sepsis patients. The inclusion of cardiac output monitoring in treatments provides valuable information on the volume tissue perfusion and oxygen delivery. Low-cardiac output indicates that there is insufficient circulation and potential starvation of vital internal organs.

In instances of low cardiac output, circulation will be diverted from the gut in order to supply the heart, brain and skeletal muscles with oxygen. Insufficient volumes of oxygen and glucose to cells can cause irreversible damage and result in deterioration of the patients' condition, possibly leading to death.

Key Topics Covered:

Executive Summary

1. Research Methodology

2. Cardiac Output Monitoring Market

2.1 Introduction

2.1.1 The Fick Principle

2.1.2 Dilution Methods

2.1.3 Doppler Ultrasound Methods

2.1.4 Pulse Pressure Methods

2.1.5 Other Methods

2.2 Market Overview

2.3 Market Analysis And Forecast

2.3.1 Total Pulmonary Artery Catheter Market

2.3.2 Total Minimally Invasive Cardiac Output Monitoring Market

2.3.3 Total Non-Invasive Cardiac Output Monitoring Market

2.4 Drivers And Limiters

2.4.1 Market Drivers

2.4.2 Market Limiters

2.5 Competitive Market Share Analysis

Companies Mentioned

  • Medtronic
  • Philips Healthcare
  • Masimo
  • GE Healthcare
  • Edwards Lifesciences
  • Mindray Medical
  • Natus Medical
  • Honeywell Life Sciences
  • Welch Allyn
  • Omron Healthcare
  • Nihon Kohden
  • Spacelabs Healthcare
  • St. Jude Medical
  • Nonin Medical
  • Boston Scientific

For more information about this report visit http://www.researchandmarkets.com/research/whxlg5/us_market_report

Related Topics: Cardiovascular Devices

Media Contact:

Research and Markets

Laura Wood, Senior Manager


For E.S.T Office Hours Call +1-917-300-0470

For U.S./CAN Toll Free Call +1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907

Fax (outside U.S.): +353-1-481-1716

© 2016 PR Newswire